March 2, 2017

VIENNA - Gadolinium phobia remains a very real danger in Europe, but practical measures can help to reduce the risk, according to Dr. Johannes Heverhagen, PhD, professor and head of radiology at the University Hospital of Bern in Switzerland. In advance of Friday's ECR special focus session on the safety of gadolinium contrast agents for MRI, he also provides an update on the European Medicines Agency's investigation, the results of which are expected soon.

Vi deo loading ...
Dr. Johannes Heverhagen discusses gadolinium contrast agents for MRI.

Video produced by Christof. G. Pelz I GRAFIFANT Creation. Grafik. Photo I www.grafifant.at

Group calls for global research effort into gadolinium
Two European researchers are forging ahead with their proposal to collect clinical experiences and outcomes with gadolinium-based contrast agents (GBCAs)...
EMA continues investigation of gadolinium contrast agents
Ten months after it began its review of gadolinium contrast agents, the European Medicines Agency (EMA) has announced it is still continuing to assess...
Study: Gadolinium contrast can enter brain by CSF
Cerebrospinal fluid (CSF) is a potential pathway for gadolinium-based contrast agents into brain tissue, according to a new rat study published online...
Danger of 'gadolinium phobia' looms in Europe
VIENNA - There's a serious risk of a phobia developing over the use of gadolinium-based MRI contrast agents, following the recent publication of a stinging...
Risks of gadolinium contrast: Where are we now?
The U.S. Food and Drug Administration has rekindled concern over gadolinium-based contrast agents by announcing a fresh investigation into the risks of...

Copyright © 2017 AuntMinnieEurope.com

Last Updated hh 3/13/2017 10:14:58 AM